Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trans-endocytosis of intact IL-15Rα–IL-15 complex from presenting cells into NK cells favors signaling for proliferation
Olga M. Antón, Mary Peterson, Michael J. Hollander, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 117, Iss. 1, pp. 522-531
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Natural killer cells in antitumour adoptive cell immunotherapy
Tamara Laskowski, Alexander Biederstädt, Katayoun Rezvani
Nature reviews. Cancer (2022) Vol. 22, Iss. 10, pp. 557-575
Open Access | Times Cited: 489
Engineering interferons and interleukins for cancer immunotherapy
Patrick G. Holder, Shion A. Lim, Christine Huang, et al.
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114112-114112
Open Access | Times Cited: 96
When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer
Mohamed S. Hasim, Marie Marotel, Jonathan J. Hodgins, et al.
Science Advances (2022) Vol. 8, Iss. 15
Open Access | Times Cited: 73
Transcription Factors Associated With IL-15 Cytokine Signaling During NK Cell Development
Xiang Wang, Xiaosu Zhao
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 84
Myokines and Heart Failure: Challenging Role in Adverse Cardiac Remodeling, Myopathy, and Clinical Outcomes
Alexander Е. Berezin, Alexander A. Berezin, Michael Lichtenauer
Disease Markers (2021) Vol. 2021, pp. 1-17
Open Access | Times Cited: 64
Interleukin-15 in autoimmunity
Hugues Allard‐Chamard, Hemant Kumar Mishra, Madhuparna Nandi, et al.
Cytokine (2020) Vol. 136, pp. 155258-155258
Closed Access | Times Cited: 62
Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy
Silvia Gaggero, Kristina Witt, Mattias Carlsten, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 52
NKTR-255, a novel polymer-conjugated rhIL-15 with potent antitumor efficacy
Takahiro Miyazaki, Mekhala Maiti, Marlene Hennessy, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 5, pp. e002024-e002024
Open Access | Times Cited: 45
Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting FcεRIγ expression
Avishai Shemesh, Yapeng Su, Daniel R. Calabrese, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 11
Open Access | Times Cited: 35
The role of interleukin-15 in the development and treatment of hematological malignancies
Paola Del Sindaco, Hritisha Pandey, Colleen Isabelle, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo
Renata Nacasaki Silvestre, Jiří Eitler, Júlia Teixeira Cottas de Azevedo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Human NK cells and cancer
Claudia Cantoni, Michela Falco, Massimo Vitale, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Natural killer (NK) cell-based immunotherapies and the many faces of NK cell memory: A look into how nanoparticles enhance NK cell activity
Idoia Mikelez-Alonso, Susana Magadán, África González‐Fernández, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113860-113860
Closed Access | Times Cited: 41
Vertebrate cell culture as an experimental approach – limitations and solutions
Mohammad Abbas, Fereshteh Moradi, Wenyu Hu, et al.
Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology (2021) Vol. 254, pp. 110570-110570
Closed Access | Times Cited: 30
Spatiotemporally programming cytokine immunotherapies through protein engineering
Luciano Santollani, K. Dane Wittrup
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 10-28
Closed Access | Times Cited: 10
Cytokines in Focus: IL-2 and IL-15 in NK Adoptive Cell Cancer Immunotherapy
Bryan Marr, Donghyeon Jo, Mihue Jang, et al.
Immune Network (2025) Vol. 25, Iss. 2
Open Access
Deciphering the localization and trajectory of human natural killer cell development
Everardo Hegewisch-Solloa, Ansel P. Nalin, Aharon G. Freud, et al.
Journal of Leukocyte Biology (2023) Vol. 114, Iss. 5, pp. 487-506
Closed Access | Times Cited: 9
The implications of IL-15 trans-presentation on the immune response
Thomas A. Waldmann, Robert Waldmann, Jian‐Xin Lin, et al.
Advances in immunology (2022), pp. 103-132
Open Access | Times Cited: 12
Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cure
Rafaëla Schober, Bianca Brandus, Thessa Laeremans, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Causal relationship between primary headache mediated by circulating cytokines and cerebral cortex structure: a mediation Mendelian randomization study
Tao Zheng, Na Zeng, Guanglu Li, et al.
Cerebral Cortex (2024) Vol. 34, Iss. 9
Closed Access | Times Cited: 2
IL15 and Anti–PD-1 Augment the Efficacy of Agonistic Intratumoral Anti-CD40 in a Mouse Model with Multiple TRAMP-C2 Tumors
Wei Chen, Richard N. Bamford, Elijah F. Edmondson, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 10, pp. 2082-2093
Open Access | Times Cited: 10
New Possible Ways to Use Exosomes in Diagnostics and Therapy via JAK/STAT Pathways
G. Gombos, Nikolett Németh, Ondrej Pös, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1904-1904
Open Access | Times Cited: 5
IFN-γ Induces IL-15 Trans-Presentation by Epithelial Cells via IRF1
Tae-Shin Kim, Min‐Seok Rha, Eui‐Cheol Shin
The Journal of Immunology (2021) Vol. 208, Iss. 2, pp. 338-346
Open Access | Times Cited: 11
A homodimeric IL-15 superagonist F4RLI with easy preparation, improved half-life, and potent antitumor activities
Liangyin Lv, Hui Wang, Wenqiang Shi, et al.
Applied Microbiology and Biotechnology (2022) Vol. 106, Iss. 21, pp. 7039-7050
Closed Access | Times Cited: 7
Manipulating NK cellular therapy from cancer to invasive fungal infection: promises and challenges
Bernice Oh, Louis Wei Yong Chan, Louis Yi Ann Chai
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top